Xenova's divestment strategy

By BC Staff | Apr 5, 1999 | 7:00 AM GMT

Xenova Group plc (LSE:XEN; XNVAY) is half way on its back-to-basics mission and focusing on developing oncology products. While some companies are planning survival by broadening their technology platforms, XEN has decided that the key to its long term sustainability and value is its therapeutic pipeline.

XEN has two